Comparison of Latent Inhibition Mechanisms before and after Drug Therapy in Patients with Schizophrenia
Author(s):
Abstract:
Introduction
This study was aimed to compare the latent inhibition mechanisms (LI) in patients at the acute phase of schizophrenia with the patients whose symptoms were controlled by antipsy- chotic medications.Method
LI was evaluated using visual and auditory stimuli in three groups: The first group (n=30) included the patients at the acute psychotic phase that did not take any medication. The second group (n=35) were the patients whose symptoms were controlled by antipsychotic drugs. The third group (n=31) were normal controls with no history of schizophrenia. The error score in learning in the testing phase was regarded as a dependent variable.Results
The error scores in schizophrenia patients (acute phase and stable patients) were signifi-cantly higher as compared to the control group. The expected effect of LI was not observed in stable schizophrenia patients. Conclusion
Our results did not show an association between LI and the phases of schizophrenia. It seems that patient's unfamiliarity with the testing technology has influenced the findings.Language:
Persian
Published:
Iraninan Psychiatry and Clinical Psychology, Volume:11 Issue: 1, 2005
Page:
24
magiran.com/p277761
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یکساله به مبلغ 1,390,000ريال میتوانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
- حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران میشود.
- پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانههای چاپی و دیجیتال را به کاربر نمیدهد.
In order to view content subscription is required
Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!